Actively Recruiting
Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients With Rotator Cuff Disease
Led by Seoul National University Hospital · Updated on 2026-04-29
21
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate safety and efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease
CONDITIONS
Official Title
Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients With Rotator Cuff Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female 19 years of age and older
- Unilateral shoulder pain lasting at least 3 months
- No response to conservative treatment
- No improvement after at least 3 months of medication, injection therapy, physical therapy, or exercise
- Partial-thickness rotator cuff tear confirmed by MRI or ultrasound
- No restrictions on clinical trial procedures including hospitalization
You will not qualify if you...
- Received subacromial injection therapy on the affected shoulder within the past 3 months
- Underwent rotator cuff surgery on the affected shoulder within the past 6 months
- History of stem cell therapy for the shoulder
- Complete rotator cuff tear, adhesive capsulitis, or isolated acromioclavicular joint arthropathy
- Radiological findings of malignancy, severe osteoarthritis of the glenohumeral joint, or skeletal abnormalities reducing subacromial space
- Symptomatic cervical spine disorders
- Concurrent bilateral shoulder pain
- Polyarthritis, infectious arthritis, rheumatoid arthritis, or fibromyalgia
- Neurological deficit
- Pregnant or lactating women
- Unwillingness to use effective contraception during the trial
- Current HBV, HCV, or HIV infections, or positive RPR test
- Severe diseases affecting the trial, including cardiovascular, renal, liver, endocrine disorders, or malignancies
- Unable to understand questionnaires or psychiatric disorders impairing communication
- Unwilling or unable to comply with follow-up schedules
- Participation in another clinical trial within the last 3 months
- Deemed unsuitable by investigator for trial participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Seoul, Korea, South Korea, 07061
Actively Recruiting
Research Team
K
KeeJeong Bae, Principal Investigator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here